Cowealth Medical China Co.,Ltd. (SHA:603122)
China · Delayed Price · Currency is CNY 16.30
+0.14 (0.87%)
Mar 18, 2026, 4:00 PM EDT
Cowealth Medical China Revenue
In the year 2025, Cowealth Medical China had annual revenue of 677.79M CNY, down -27.83%. Cowealth Medical China had revenue of 128.93M in the quarter ending December 31, 2025, a decrease of -43.49%.
Revenue
677.79M
Revenue Growth
-27.83%
P/S Ratio
9.57
Revenue / Employee
3.34M
Employees
203
Market Cap
6.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 677.79M | -261.35M | -27.83% |
| Dec 31, 2024 | 939.14M | -153.46M | -14.05% |
| Dec 31, 2023 | 1.09B | -187.06M | -14.62% |
| Dec 31, 2022 | 1.28B | 88.61M | 7.44% |
| Dec 31, 2021 | 1.19B | 102.04M | 9.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 10.50B |
| Shanghai Runda Medical Technology | 7.40B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Medicalsystem Biotechnology | 1.47B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.20B |